Bentazepam

This classification denotes a sedative, hypnotic, and anxiolytic with the molecular formula C17H16N2OS, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 66JKK43S1Z, chemically known as 1,3,6,7,8,9-hexahydro-5-phenyl-2h-(1)benzothieno(2,3-e)-1,4-diazepin-2-one but generally known as bentazepam, which bears US NIH Compound Identifier 34592. European Medicines Agency schedules Bentazepam in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05733MIG. The term BENTAZEPAM is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 29, No. 10 1975, List 15). BENTAZEPAM is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule bentazepam under HS 29349990 and SITC 51579. As of Q4 2014, BENTAZEPAM remains the US FDA Preferred Term for this commodity. Bentazepam bears US NLM identifiers UMLS ID C0053117 and NCI Concept Code C74189. SMILES: S1C2C(CCCC2)C2=C(NCC(=O)N=C12)C1CCCCC1.